Opportunity Information: Apply for PA 09 022
Apply for PA 09 022
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "International Research Collaboration on Drug Abuse and Addiction Research (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Oct 29, 2008 and posted on Oct 29, 2008.
- Applicants must submit their applications by Jan 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education For profit organizations other than small businesses County governments Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The International Research Collaboration on Drug Abuse and Addiction Research (R03) opportunity (Funding Opportunity Number PA-09-022) is a National Institutes of Health grant announcement focused on supporting small-scale, collaborative research projects in drug abuse and addiction that specifically benefit from conducting part of the work outside the United States. The central idea is that certain research questions can move faster or be answered more convincingly when investigators partner internationally to access unique expertise, distinctive scientific resources, particular populations, or environmental and contextual conditions that are not readily available in the U.S. Projects are expected to align with the mission of the National Institute on Drug Abuse (NIDA) and, when possible, connect to NIDA scientific priority areas, which may shift from year to year. For the FY2009 framing referenced in the announcement, examples of priority topics included the links between HIV/AIDS and drug abuse, methamphetamine abuse, inhalant abuse, smoking during pregnancy, and the relationship between drugs and driving.
This FOA uses the NIH Small Research Grant mechanism (R03), which is designed for smaller, tightly scoped studies that can be completed in a relatively short timeframe with limited resources. The R03 mechanism is commonly used for pilot and feasibility work, secondary analyses of existing datasets, small self-contained projects that answer a focused question, and the development or refinement of research methods or technologies. In practice, that means the program is well-suited for projects that need enough funding to test an approach, establish proof-of-concept, generate preliminary data, validate a measurement strategy, or leverage existing international data or infrastructure, rather than supporting a large multi-year program of research.
The announcement notes that PA-09-022 is part of a set of parallel opportunities with the same scientific scope but different NIH grant mechanisms. Applicants with a larger or more complex research plan could look to the companion FOAs that use the R01 (Research Project Grant) or R21 (Exploratory/Developmental Grant) mechanisms, while this specific FOA targets the smaller R03 format.
In terms of funding parameters, the award ceiling listed is $50,000, and the total number and size of awards are not fixed in advance. Instead, NIH indicates that award amounts and project durations can vary depending on the proposed scope, the quality of applications received, and available funds. There is no cost sharing or matching requirement, which reduces barriers for applicants who may not have non-federal funds available to contribute.
Eligibility is broad and includes many U.S. organization types such as public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status, as described), state and local governments, independent school districts, small businesses, and certain for-profit organizations. The FOA also explicitly includes a range of mission-driven and culturally focused institution types (for example, Historically Black Colleges and Universities, Hispanic-Serving Institutions, Tribal Colleges and Universities, and Alaska Native and Native Hawaiian Serving Institutions), along with faith-based and community-based organizations where appropriate. Importantly for an international collaboration program, non-domestic (non-U.S.) entities and foreign organizations are also listed as eligible, reflecting the program’s intent to enable genuine cross-border research partnerships.
Administratively, the opportunity is categorized as a discretionary grant within the Education/Health activity category and is associated with CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The FOA was posted on October 29, 2008, with an original and current closing date of January 7, 2012, and it was archived on February 7, 2012. The full announcement was made available through the NIH grants guide, and the listed contact for access or linking issues is the NIH Office of Extramural Research webmaster (FBOWebmaster@OD.NIH.GOV).
FAQs: International Research Collaboration on Drug Abuse and Addiction Research (R03) - PA-09-022
What is this funding opportunity?
This is an NIH grant announcement titled International Research Collaboration on Drug Abuse and Addiction Research (R03), Funding Opportunity Number PA-09-022. It supports small-scale, collaborative research projects in drug abuse and addiction research that specifically benefit from conducting part of the work outside the United States.
What is the main purpose of PA-09-022?
The central goal is to speed up progress or strengthen conclusions by enabling international partnerships that provide access to unique expertise, distinctive scientific resources, particular populations, or environmental and contextual conditions not readily available in the U.S.
Which NIH institute is this opportunity aligned with?
Projects are expected to align with the mission of the National Institute on Drug Abuse (NIDA).
Does the FOA require a connection to NIDA priority areas?
The announcement indicates that projects should align with NIDA's mission and, when possible, connect to NIDA scientific priority areas. It also notes that these priority areas may shift from year to year.
What are examples of priority topics mentioned in the announcement?
For the FY2009 framing referenced in the announcement, examples included:
- Links between HIV/AIDS and drug abuse
- Methamphetamine abuse
- Inhalant abuse
- Smoking during pregnancy
- The relationship between drugs and driving
What grant mechanism does PA-09-022 use?
This FOA uses the NIH Small Research Grant (R03) mechanism, designed for smaller, tightly scoped studies that can be completed in a relatively short timeframe with limited resources.
What kinds of projects are a good fit for the R03 mechanism under this FOA?
The announcement describes the R03 as commonly used for:
- Pilot and feasibility studies
- Secondary analyses of existing datasets
- Small, self-contained projects addressing a focused research question
- Development or refinement of research methods or technologies
In practical terms, this FOA is well-suited for projects that test an approach, establish proof-of-concept, generate preliminary data, validate measurement strategies, or leverage existing international data or infrastructure, rather than supporting a large multi-year program of research.
Does this opportunity require international collaboration?
Yes. The opportunity is specifically focused on collaborative research projects where part of the work is conducted outside the U.S., and where the international component is important because it provides access to resources, expertise, populations, or contexts that are not easily available domestically.
Are there related opportunities for larger projects?
Yes. The announcement notes that PA-09-022 is part of a set of parallel opportunities with the same scientific scope but different NIH grant mechanisms. Applicants with larger or more complex research plans could consider companion FOAs using the R01 (Research Project Grant) or R21 (Exploratory/Developmental Grant) mechanisms.
What is the award ceiling for this FOA?
The listed award ceiling is $50,000.
Are the number of awards and award sizes predetermined?
No. The total number and size of awards are not fixed in advance. NIH indicates that award amounts and project durations may vary based on the proposed scope, the quality of applications received, and available funds.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad. The FOA includes many U.S. organization types such as public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status as described), state and local governments, independent school districts, small businesses, and certain for-profit organizations.
Are non-U.S. (foreign) organizations eligible?
Yes. The FOA explicitly lists non-domestic (non-U.S.) entities and foreign organizations as eligible, consistent with the program's focus on international research collaboration.
Does the FOA mention specific institution categories as eligible?
Yes. The FOA explicitly includes institution types such as:
- Historically Black Colleges and Universities (HBCUs)
- Hispanic-Serving Institutions
- Tribal Colleges and Universities
- Alaska Native and Native Hawaiian Serving Institutions
- Faith-based organizations (where appropriate)
- Community-based organizations (where appropriate)
How is this opportunity categorized administratively?
The opportunity is categorized as a discretionary grant within the Education/Health activity category, and is associated with CFDA 93.279 (Drug Abuse and Addiction Research Programs).
When was PA-09-022 posted, and what were the closing details?
The FOA was posted on October 29, 2008. The original and current closing date listed is January 7, 2012. The opportunity was archived on February 7, 2012.
Where was the full announcement made available?
The full announcement was made available through the NIH grants guide.
Who should be contacted for access or linking issues related to the announcement?
The listed contact for access or linking issues is the NIH Office of Extramural Research webmaster: FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Disaster Assistance for State Units on Aging (SUAs) and Title VI Tribal Organizations in National Disasters Declared by the President
Previous opportunity: International Research Collaboration on Drug Abuse and Addiction Research (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 09 022
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 09 022) also looked into and applied for these:
| Funding Opportunity |
|---|
| Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R21) Apply for RFA DA 09 018 Funding Number: RFA DA 09 018 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Secondary Data Analyses for Substance Abuse Research (R21/R33) Apply for RFA DA 09 020 Funding Number: RFA DA 09 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Brain Imaging Studies of Negative Reinforcement in Humans (R01) Apply for RFA DA 09 008 Funding Number: RFA DA 09 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Brain Imaging Studies of Negative Reinforcement in Humans (R21) Apply for RFA DA 09 009 Funding Number: RFA DA 09 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Instrument Development for Biomedical Applications (R21) Apply for RFA RR 09 001 Funding Number: RFA RR 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| Erythropoiesis Stimulating Agents and Tumor Progression (R01) Apply for PA 09 023 Funding Number: PA 09 023 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Erythropoiesis Stimulating Agents and Tumor Progression (R21) Apply for PA 09 024 Funding Number: PA 09 024 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| National Cancer Institute Program Project (P01) Applications Apply for PAR 09 025 Funding Number: PAR 09 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 09 026 Funding Number: PAR 09 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Education Programs of Excellence in Scientifically Validated Behavioral Treatment (R25) Apply for RFA MH 09 110 Funding Number: RFA MH 09 110 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Shared Instrumentation Grant Program (S10) Apply for PAR 09 028 Funding Number: PAR 09 028 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Mutant Mouse Regional Resource Centers (Limited Competition U42) Apply for RFA RR 09 003 Funding Number: RFA RR 09 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mutant Mouse Regional Resource Centers (U42) Apply for RFA RR 09 002 Funding Number: RFA RR 09 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| STUDIES OF ENERGY BALANCE AND CANCER IN HUMANS Apply for PA 04 124 Funding Number: PA 04 124 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows (F31) in Nursing Research Apply for PAR 05 091 Funding Number: PAR 05 091 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| IDeA Networks of Biomedical Research Excellence (INBRE) P20 Apply for PAR 08 150 Funding Number: PAR 08 150 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 08 225 Funding Number: PAR 08 225 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2008 and 2009 (P50) Apply for PAR 08 020 Funding Number: PAR 08 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Cooperative Drug Discovery and Development Groups (NCDDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01/U19) Apply for PAR 08 238 Funding Number: PAR 08 238 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) Apply for PAR 08 245 Funding Number: PAR 08 245 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 022", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.